Discussion
Pediatric patients with severe TBI remain at substantial risk for mortality, which is demonstrated by the 26.8% incidence of in-hospital mortality within our cohort. This is similar to mortality incidences reported in previous pediatric studies (16%–28%).11–14 Though predictive scales, models, and algorithms have been implemented to prognosticate acute and long-term outcomes, less attention has been given to using data from the initial resuscitation to predict mortality risk. Therefore, our study analyzed pediatric patients who were intubated with severe TBI with an aim to identify associations between clinical variables collected during trauma assessment and in-hospital mortality. Initial INR, platelet count, and blood glucose were significantly associated with in-hospital mortality. An INR greater than 2.3 was associated with at least a 50% chance of mortality among blunt trauma patients, which is consistent with prior literature demonstrating an association between elevated INR and in-hospital mortality in children with abusive head trauma.15 Coagulopathy following TBI is well described in the literature and may be due to the release of tissue factor.16 Increasing GCS score was associated with decreased odds of mortality.
As in our study, other attempts have been made to predict survival of pediatric TBI on initial presentation. However, much of the focus is on the use of CT imaging, the gold standard for diagnosing intracranial injuries among children.17 The CT Rotterdam score has been found to be significantly related to TBI outcome and is often used as a predictor of mortality.18–21 The score is assigned based on CT evaluation of the basal cistern, midline shift, an epidural mass lesion, and intraventricular hemorrhage or subarachnoid hemorrhage. Talari et al. demonstrated that each 1-point increase in Rotterdam score was associated with a 10.5-times increase in mortality rate. They also identified that scores ≥3 were associated with a mortality rate of 65.5%, compared with scores <3, which were associated with a mortality rate of 0.6%.18 More recently, Dornbos III et al. published a retrospective study validating the Surgical Intervention for Traumatic Injury Scale in pediatric patients. This scale is based on both radiographic and clinical findings defined by neurosurgical guidelines and expert clinical experience. It was also created to rapidly identify patients with TBI at the highest risk for mortality, though it is specifically used to determine those who would likely need emergent decompression. Results demonstrated that a score threshold of 2 (sensitivity of 96.4%, specificity of 86.9%) was indicative of needing emergent surgery.1 2 While our study did not aim to determine which patients would be most likely to require emergent decompression, there was a notably higher rate of emergent craniectomies among patients who died, consistent with their overall clinical picture of critical illness.
There are also a limited number of reports within the literature linking laboratory values to acute and long-term outcomes of severe TBI, though with varying results.22–24 For example, in a large cohort of 1129 pediatric patients with TBI, an initial hematocrit ≤30% or a platelet count of greater than 400 000 on presentation was associated with an increased likelihood of abusive head trauma in children <5 years old.23 Another study demonstrated that children with severe TBI who experienced a physiologic death compared with children undergoing withdrawal of life-sustaining devices had higher partial thromboplastin time (PTT) and lower albumin levels on admission.14 Results from the IMPACT study (2007) used 6-month GOS as an endpoint and demonstrated that prothrombin time (PT) and glucose were strong predictors of outcomes, while hemoglobin and platelets were also predictors but to a lesser extent.24 Podolsky-Gondim et al. demonstrated that abnormal PT, fibrinogen, and platelet count were associated with worse GOS outcomes at 1 and 6 months and found PT and PTT to be associated with mortality risk.25 Most recently, Fu et al. studied 213 children with moderate to severe TBI at their tertiary pediatric hospital and found that admission lactate levels and GCS score were independent risk factors for in-hospital mortality, while glucose, hemoglobin, and hypotension were not significantly associated. Elevated lactate was also associated with a greater number of ventilator days, ICU days, and hospital days.22 Of note, procalcitonin levels have also been studied in adult TBI patients, and results do not support their utility in predicting in-hospital mortality.26 In our study, INR and blood glucose were significantly associated with in-hospital mortality, causing 14.3-fold higher odds of mortality with each 1.0 unit increase in INR and a 1% increase in odds with each increase in blood glucose by 10 mg/dL.
Studies utilizing physical exam findings to predict outcomes of severe TBI have demonstrated more consistency. There is substantial evidence that GCS score is a significant predictor of mortality.13 18 19 22 25 27–29 Studies have reported a 0.37-times to a 0.68-times decreased mortality rate with each 1-point increase in GCS score, which is similar to the 0.68-times decrease demonstrated in our study.18 22 The IMPACT study has also identified the GCS motor score and pupillary response as being the most powerful predictors of GOS, with GCS eye and verbal scores also being strong predictors.24 In a study by Fulkerson et al., 67 pediatric patients with a GCS score of 3 or 4 were evaluated for survival to discharge as well as long-term outcomes by GOS. They found that the highest correlation with survival in these patients was pupillary reaction, with a survival probability of 23% if one or both eyes was abnormal on examination, compared with a survival probability of 87% if reflexes in both eyes were normal. The second-strongest predictor of mortality was hypothermia, defined as <36°C. Patients with an absent pupillary reflex and hypothermia were predicted to have a 14% chance of survival, while patients with absent reflexes and no hypothermia had a 56% chance of survival.30 Pupillary response and temperature were not found to be a significant predictor for mortality among our patients. This may be due to the relationship between hypothermia and poor pupillary response with the other indicators of critical illness among our patients. Though prophylactic hypothermia in pediatric TBI is of great interest as a potential treatment, it remains controversial and has not been proven to demonstrate a benefit in mortality and long-term outcomes among our patients or in other studies.31–33
Although our findings identify a correlation between INR, platelet count, and blood glucose values collected during initial trauma resuscitation and mortality in pediatric patients with severe TBI, it is important to recognize that these clinical variables often do not act in isolation. Some pathologies and clinical circumstances confound patients’ hypo/hyperglycemia and coagulopathy. For example, liver failure, renal disease, diabetes, ongoing hemorrhage, prolonged transport time, and/or systemic anticoagulation may contribute to abnormal INR, platelet count, and blood glucose values in patients presenting with severe TBI. Therefore, if we are to target specific parameters of these values, management should also consider their interrelatedness and the correction of underlying, compounding clinical pathology. While findings from this study identify INR and blood glucose as having the most direct correlation with mortality in pediatric patients with severe TBI, further studies are needed to examine the value of targeting specific parameters of these variables, which may contribute to the creation of potential standardized algorithms targeting parameters that improve survival. Algorithms can help guide trauma teams during the high-acuity resuscitation of critically ill pediatric patients with severe TBI, particularly in hospitals that do not routinely manage this pathology or patient population. Studies identifying parameters of patient age, weight, and GCS score, that are more likely to be associated with mortality, could be factored into these algorithms to guide providers in communicating survival expectations to caregivers and in escalating care to pediatric hospitals with neurosurgical capabilities. These data also provide insight into targeted intervention methods such as improving coagulopathy and abnormal glucose levels prior to presentation to the trauma center to perhaps improve outcomes.
Limitations
As in any retrospective cohort study, there were limitations related to the retrospective nature of the study. We did not have control over missing data, misclassified data, or data granularity. Additionally, in-hospital mortality was the outcome measured. Its binary nature did not account for other clinical outcomes or quality of life measures, which are also relevant when evaluating pediatric TBI patients. Furthermore, mortality outcomes after discharge from the index hospitalization are unknown and unaccounted for. Survival may be over-represented in this cohort due to the possibility that patients may have experienced a mortality secondary to their TBI after discharge.
Additionally, patient-specific comorbidities were not captured and could act as confounders that were not controlled for in our analyses. However, ISS, hAIS, and GCS score were utilized to control for injury severity among patients, specifically GCS score and hAIS to account for head injury severity and ISS to account for patients presenting with multiple regions of injury. While GCS score can be rapidly calculated and used to assess acute changes in neurologic status, we recognize that the clinical utility of hAIS may be limited during the initial triage of the patient since it is typically calculated during admission. However, hAIS has been shown in previous studies to better reflect in-hospital mortality than GCS score, so remains an important factor in prognostication following a patient’s initial resuscitation.34
Finally, we evaluated intubated patients with severe TBI and did not have the granular data available to identify sedatives or neuromuscular blocking agents given prior to the patient’s arrival. This could limit the accuracy of some of the neurological assessments of some patients, creating misclassification bias; however, the GCS is a well-recognized neurological assessment tool and was determined by an experienced Emergency Department or Trauma Surgery physician.18
Ultimately, INR and blood glucose values collected during initial trauma resuscitation in pediatric trauma patients intubated with severe TBI were associated with higher odds of in-hospital mortality. Further studies are needed to examine whether earlier interventions targeting specific parameters of these clinical variables impact mortality.